ODDB.org: Open Drug Database

Future Health Pharma GmbH - IXIARO, Injektionssuspension

Swissmedic Registration	59147	Sequence	01
Product name	IXIARO	Description	Injektionssuspension
ATC-Classification	J07BA02	ATC-Description	Encephalitis, Japanese, Inactivated, Whole Virus
Introduction of Sequence	06.05.2010

Composition

enzephalitidis japanensis viri antigenum (Stamm: SA-14-2) 6.0 U., aluminium ut aluminii hydroxidum hydricum ad adsorptionem, kalii dihydrogenophosphas, dinatrii phosphas, natrii chloridum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. kalium 21 µg, natrium 1.9 mg.

Packungsbestandteile

Galenic Form

Injection suspension

Excipiens

Active Agent	Dose
Enzephalitidis Japanensis viri Antigenum (Stamm: Sa-14-2)	6U. / 0.5ml

Inactive agents
Alumine
Disodium Phosphate
Potassium Dihydrogenophosphate
Sodium Chloride

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	syringe(s)			B		No

2026	©ywesee GmbH